Latest Earnings
Equities
Stock Analysis
Stock Movers
Deals
Gainers And Losers
IPOs
Technology
Artificial Intelligence
Web Stories
Benzinga Inspire
Marksans Pharma
This Pharma Stock Has Slumped 11% In 30 Days, But Analysts Forecast Over 110% Rally Ahead
Shares of Marksans Pharma have been on a downtrend since the start of the year. In the last 30 days, the stock has called around 11%, but analysts at Ventura are optimistic about the company's growth prospects.
This Pharma Stock Has Slumped 11% In 30 Days, But Analysts Forecast Over 110% Rally Ahead
